Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPOD: Posaconazole prophylaxis in children with chronic granulomatous disease
2008-004518-28Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of posaconazole in chronic granulomatous disease (CGD), sponsored by Radboud University Medical Center. Primary endpoint: Individual trough posaconazole plasma concentrations. Started Nov 2008; status: completed.
02
Drugs
posaconazole
03
Conditions
chronic granulomatous disease (CGD)
Beyond the preview
Go deeper on 2008-004518-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004518-28.